Showing results (1-10 of 236) with videos related to
Sort By:
Pageof 24
Investigational New Drugs|June 1, 2000
Development of target-based antineoplastic agentsW M Stadler, M J RatainClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrheaF Innocenti, W M Stadler, L Iyer, et al.Cancer|April 7, 1998
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trialB I Rini, W M Stadler, R T Spielberger, et al.Cancer|December 18, 2001
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignanciesS Mani, N J Vogelzang, D Bertucci, et al.Cancer Chemotherapy and Pharmacology|June 15, 2000
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrationsB C Goh, G F Fleming, L Janisch, et al.Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.Seminars in Oncology|August 1, 1992
Therapeutic relevance of pharmacokinetics and pharmacodynamicsM J RatainAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumorsA A Desai, R L Schilsky, A Young, et al.Clinical Pharmacology and Therapeutics|February 28, 2013
Estimation of renal cell carcinoma treatment effects from disease progression modelingM L Maitland, K Wu, M R Sharma, et al.Pageof 24